HPV infection in men

Disease Markers

Volumn 23, Issue 4, 2007, Pages 261-272

  Palefsky, Joel M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anal cancer; Anal HPV infection; Anal intraepithelial neoplasia; Condyloma; HIV; Penile cancer; Penile HPV infection; Penile intraepithelial neoplasia

Indexed keywords

ANTIRETROVIRUS AGENT; FLUOROURACIL; IMIQUIMOD; INTERFERON; LIQUID NITROGEN; PODOPHYLLOTOXIN; TRICHLOROACETIC ACID; WART VIRUS VACCINE;

ANUS CANCER; ANUS DISEASE; CANCER RADIOTHERAPY; CANCER SCREENING; CARCINOGENESIS; CONDYLOMA; DISEASE ASSOCIATION; DISEASE COURSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MALE GENITAL SYSTEM; MALE HOMOSEXUAL; MORTALITY; NONHUMAN; PENIS DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SAMPLING; SEX DIFFERENCE; SEXUAL TRANSMISSION; SEXUALITY; UTERINE CERVIX; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS; WOMEN'S HEALTH;

HUMAN PAPILLOMAVIRUS;

EID: 34347371079     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2007/159137     Document Type: Review

References (78)

1. S.B. Baldwin, D.R. Wallace and M.R. Papenfuss, Human papillomavirus infection in men attending a sexually transmitted disease clinic, J Infect Dis 187 (2003), 1064-1070.
2. S.M. Nicolau, C.G. Camargo and J.N. Stavale, Human papillomavirus DNA detection in male sexual partners of women with genital human papillomavirus infection, Urology 65 (2005), 251-255.
3. S. Vaccarella, E. Lazcano-Ponce and J.A. Castro-Garduno, Prevalence and determinants of human papillomavirus infection in men attending vasectomy clinics in Mexico, Int J Cancer 119 (2006), 1934-1939.
4. S.B. Baldwin, D.R. Wallace, M.R. Papenfuss, M. Abrahamsen, L.C. Vaught and A.R. Giuliano, Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic, Sex Transm Dis 31 (2004), 601-607.
5. M. Frisch, R.J. Biggar and J.J. Goedert, Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome, J Natl Cancer Inst 92 (2000), 1500-1510.
6. G. Sirera, S. Videla and M. Pinol, High prevalence of human papillomavirus infection in the anus, penis and mouth in HIV-positive men, AIDS 20 (2006), 1201-1204.
7. R. Barrasso, J. De Brux, O. Croissant and G. Orth, High prevalence of papillomavirus-associated penile intraepithelial neoplasia in sexual partners of women with cervical intraepithelial neoplasia, N Engl J Med 317 (1987), 916-923.
8. J.M. Palefsky and R. Barrasso, HPV infection and disease in men, Obstet Gynecol Clin North Am 23 (1996), 895-916.
9. M.C. Bleeker, C.J. Hogewoning and F.J. Voorhorst, Condom use promotes regression of human papillomavirus-associated penile lesions in male sexual partners of women with cervical intraepithelial neoplasia, Int J Cancer 107 (2003), 804-810.
10. A.B. Ackerman and R. Kronberg, Pearly penile papules. Acral angiofibromas, Arch Dermatol 108 (1973), 673-675.
11. R. Barrasso and S. Jablonska, Clinical, colposcopic and histologic spectrum of male human papillomavirus-associated genital lesions, Clin Pract Gynecol 2 (1989), 73-101.
12. J. Palefsky and R. Barasso, HPV infection and disease in men, Obstet Gyn Clin North Am 23 (1996), 895-916.
13. T.R. Wade, A.W. Kopf and A.B. Ackerman, Bowenoid papulosis of the penis, Cancer 42 (1978), 1890-1903.
14. S. Obalek, S. Jablonska and G. Orth, HPV-associated intraepithelial neoplasia of external genitalia, Clin Dermatol 3 (1985), 104-113.
15. S. Obalek, S. Jablonska, S. Beaudenon, L. Walczak and G. Orth, Bowenoid papulosis of the male and female genitalia: risk of cervical neoplasia, J Am Acad Dermatol 14 (1986), 433-444.
16. H. Ikenberg, L. Gissmann, G. Gross, E.I. Grussendorf-Conen and H. zur Hausen, Human papillomavirus type-16-related DNA in genital Bowen's disease and in Bowenoid papulosis, Int J Cancer 32 (1983), 563-565.
17. R.U. Levine, C.P. Crum, E. Herman, D. Silvers, A. Ferenczy and R.M. Richart, Cervical papillomavirus infection and intraepithelial neoplasia: a study of male sexual partners, Obstet Gynecol 64 (1984), 16-20.
18. G. Gross and H. Pfister, Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts, Med Microbiol Immunol (Berlin) 193 (2004), 35-44.
19. D.M. Parkin, S.L. Whelan, J. Ferlay and H. Storm, Cancer Incidence in Five Continents, IARC CancerBase Lyon No. 7 (2005), I-VIII.
20. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002, MMWR 51 (2002), RR-6.
21. X. Castellsague, F.X. Bosch and N. Munoz, Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners, N Engl J Med 346 (2002), 1105-1112.
22. R.L. Winer, J.P. Hughes and Q. Feng, Condom use and the risk of genital human papillomavirus infection in young women, N Engl J Med 354 (2006), 2645-2654.
23. M.C. Bleeker, C.J. Hogewoning and A.J. Van Den Brule, Penile lesions and human papillomavirus in male sexual partners of women with cervical intraepithelial neoplasia, J Am Acad Dermatol 47 (2002), 351-357.
24. S. Franceschi, X. Castellsague and L. Dal Maso, Prevalence and determinants of human papillomavirus genital infection in men, Br J Cancer 86 (2002), 705-711.
25. M.C. Bleeker, C.J. Hogewoning and J. Berkhof, Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads, Clin Infect Dis 41 (2005), 612-620.
26. H.R. Shin, S. Franceschi and S. Vaccarella, Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea, J Infect Dis 190 (2004), 468-476.
27. J.M. Palefsky, E.A. Holly, M.L. Ralston, M. Da Costa and R.M. Greenblatt, Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women, J Infect Dis 183 (2001), 383-391.
28. N. Kiviat, A. Rompalo and R. Bowden, Anal human papillomavirus infection among human immunodeficiency virus-seropositive and -seronegative men, J Infect Dis 162 (1990), 358-361.
29. C. Piketty, T.M. Darragh and M. Da Costa, High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse, Ann Intern Med 138 (2003), 453-459.
30. J.M. Palefsky, E.A. Holly and M.L. Ralston, Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors, J Acquir Immune Defic Syndr Hum Retrovirol 17 (1998), 320-326.
31. P.V. Chin-Hong, E. Vittinghoff and R.D. Cranston, Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study, J Natl Cancer Inst 97 (2005), 896-905.
32. C.W. Critchlow, C.M. Surawicz, K.K. Holmes et al., Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: influence of HIV infection, immunosuppression and human papillomavirus infection, AIDS 9 (1995), 1255-1262.
33. C. Piketty, T.M. Darragh and I. Heard, High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy, Sex Transm Dis 31 (2004), 96-99.
34. J.M. Palefsky, E.A. Holly, M.L. Ralston, N. Jay, J.M. Berry and T.M. Darragh, High incidence of anal high-grade squamous intraepithelial lesions among HIV-positive and HIV-negative homosexual/bisexual men, AIDS 12 (1998), 495-503.
35. J.M. Palefsky, E.A. Holly and C.J. Hogeboom, Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men, J Acquir Immune Defic Syndr Hum Retrovirol 17 (1998), 314-319.
36. J.M. Palefsky, E.A. Holly and M.L. Ralston, Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection, J Acquir Immune Defic Syndr 28 (2001), 422-428.
37. J.M. Palefsky, E.A. Holly and J.T. E, Anal intraepithelial neoplasia in the HAART era among HIV-positive men who have sex with men, AIDS 19 (2005), 1407-1414.
38. M. Frisch, R.J. Biggar, E.A. Engels and J.J. Goedert, Association of cancer with AIDS-related immunosuppression in adults, JAMA 285 (2001), 1736-1745.
39. S.E. Gagne, R. Jensen and A. Polvi, High-resolution analysis of genomic alterations and human papillomavirus integration in anal intraepithelial neoplasia, J Acquir Immune Defic Syndr 40 (2005), 182-189.
40. D.M. Parkin, The global health burden of infection-associated cancers in the year 2002, Int J Cancer (2006).
41. L.G. Johnson, M.M. Madeleine, L.M. Newcomer, S.M. Schwartz and J.R. Daling, Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000, Cancer 101 (2004), 281-288.
42. J.R. Qualters, N.C. Lee, R.A. Smith and R.E. Aubert, Breast and cervical cancer surveillance, United States, 1973-1987, MMWR 41 (1992), 1-15.
43. J.R. Daling, M.M. Madeleine and L.G. Johnson, Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer, Cancer 101 (2004), 270-280.
44. J.R. Daling, N.S. Weiss and T.G. Hislop, Sexual practices, sexually transmitted diseases, and the incidence of anal cancer, N Engl J Med 317 (1987), 973-977.
45. E.A. Holly, A.S. Whittemore, D.A. Aston, D.K. Ahn, B.J. Nickoloff and J.J. Kristiansen, Anal cancer incidence: genital warts, anal fissure or fistula, hemorrhoids, and smoking, J Natl Cancer Inst 81 (1989), 1726-1731.
46. M. Frisch, B. Glimelius and A.J. van den Brule, Sexually transmitted infection as a cause of anal cancer, N Engl J Med 337 (1997), 1350-1358.
47. J.R. Daling, K.J. Sherman and T.G. Hislop, Cigarette smoking and the risk of anogenital cancer, Am J Epidemiol 135 (1992), 180-189.
48. M. Bower, T. Powles and T. Newsom-Davis, HIV-Associated Anal Cancer: Has Highly Active Antiretroviral Therapy Reduced the Incidence or Improved the Outcome? J Acquir Immune Defic Syndr 37 (2004), 1563-1565.
49. E.Y. Chiao, S.E. Krown, E.A. Stier and D. Schrag, A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic, J Acquir Immune Defic Syndr 40 (2005), 451-455.
50. M. Bower, C. Palmieri and T. Dhillon, AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy, Curr Opin Infect Dis 19 (2006), 14-19.
51. I. Penn, Cancer in the immunosuppressed organ recipient, Transplant Proc 23 (1991), 1771-1772.
52. I. Penn, The changing pattern of posttransplant malignancies, Transplant Proc 23 (1991), 1101-1103.
53. J. Adami, H. Gabel and B. Lindelof, Cancer risk following organ transplantation: a nationwide cohort study in Sweden, Br J Cancer 89 (2003), 1221-1227.
54. H.S. Patel, A.R. Silver and J.M. Northover, Anal cancer in renal transplant patients, Int J Colorectal Dis (2005), 1-5.
55. P.V. Chin-Hong and J.M. Palefsky, Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus, Clin Infect Dis 35 (2002), 1127-1134.
56. S.J. Goldie, K.M. Kuntz, M.C. Weinstein, K.A. Freedberg, M.L.Welton and J.M. Palefsky, The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men, JAMA 281 (1999), 1822-1829.
57. S.J. Goldie, K.M. Kuntz, M.C. Weinstein, K.A. Freedberg and J.M. Palefsky, Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men, Am J Med 108 (2000), 634-641.
58. N. Jay, E.A. Holly, M. Berry, C.J. Hogeboom, T.M. Darragh and J.M. Palefsky, Colposcopic correlates of anal squamous intraepithelial lesions, Dis Col Rectum 40 (1997), 919-928.
59. J.M. Palefsky, E.A. Holly, C.J. Hogeboom, N. Jay, M. Berry and T.M. Darragh, Anal cytology as a screening tool for anal squamous intraepithelial lesions, J Acq Immun Defic Syndr 14 (1997), 415-422.
60. C. Fenger and V.T. Nielsen, Precancerous changes in the anal canal epithelium in resection specimens, Acta Pathol Microbiol Immunol Scand [a] 94 (1986), 63-69.
61. T.E. Marfing, M.E. Abel and D.M. Gallagher, Perianal Bowen's disease and associated malignancies. Results of a survey, Dis Colon Rectum 30 (1987), 782-785.
62. A.B. Jaeger, A. Gramkow, H. Hjalgrim, M. Melbye and M. Frisch, Bowen disease and risk of subsequent malignant neoplasms: a population-based cohort study of 1147 patients, Arch Dermatol 135 (1999), 790-793.
63. C.A. Benson, J.E. Kaplan, H. Masur, A. Pau and K.K. Holmes, Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America, MMWR Recomm Rep 53 (2004), 1-112.
64. G.J. Chang, J.M. Berry, N. Jay, J.M. Palefsky and M.L. Welton, Surgical treatment of high-grade anal squamous intraepithelial lesions: a prospective study, Dis Colon Rectum 45 (2002), 453-458.
65. S.E. Goldstone, A.Z. Kawalek and J.W. Huyett, Infrared coagulator: a useful tool for treating anal squamous intraepithelial lesions, Dis Colon Rectum 48 (2005), 1042-1054.
66. J.H. Scholefield, Treatment of grade III anal intraepithelial neoplasia with photodynamic therapy: report of a case, Dis Colon Rectum 46(11) (2003), 1555-1559.
67. A. Kreuter, B. Hochdorfer and M. Stucker, Treatment of anal intraepithelial neoplasia in patients with acquired HIV with imiquimod 5% cream, J Am Acad Dermatol 50 (2004), 980-981.
68. J.M. Berry, J.M. Palefsky and M.L. Welton, Anal cancer and its precursors in HIV-positive patients: perspectives and management, Surg Oncol Clin N Am 13 (2004), 355-373.
69. M.A. Rubin, B. Kleter and M. Zhou, Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis, Am J Pathol 159 (2001), 1211-1218.
70. J.E. Levi, P. Rahal, A.S. Sarkis and L. Villa, Human papillomavirus DNA and p53 status in penile carcinomas, Int J Cancer 76 (1998), 779-783.
71. J.J. Carter, M.M. Madeleine and K. Shera, Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites, Cancer Res 61 (2001), 1934-1940.
72. M.R. Cupp, R.S. Malek, J.R. Goellner, T.F. Smith and M.J. Espy, The detection of human papillomavirus deoxyribonucleic acid in intraepithelial, in situ, verrucous and invasive carcinoma of the penis, J Urol 154 (1995), 1024-1029.
73. M.A. Picconi, A.M. Eijan and A.L. Distefano, Human papillomavirus (HPV) DNA in penile carcinomas in Argentina: analysis of primary tumors and lymph nodes, J Med Virol 61 (2000), 65-69.
74. A.L. Bezerra, A. Lopes, G. Landman, G.N. Alencar, H. Torloni and L.L. Villa, Clinicopathologic features and human papillomavirus dna prevalence of warty and squamous cell carcinoma of the penis, Am J Surg Pathol 25 (2001), 673-678.
75. L. Gregoire, A.L. Cubilla, V.E. Reuter, G.P. Haas and W.D. Lancaster, Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma, J Natl Cancer Inst 87 (1995), 1705-1709.
76. M. Frisch, C. Fenger and A.J. van den Brule, Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses, Cancer Res 59 (1999), 753-757.
77. P.A. Poletti, A. Halfon and M.C. Marti, Papillomavirus and anal carcinoma, Int J Colorectal Dis 13 (1998), 108-111.
78. K.R. Shroyer, C.G. Brookes, N.E. Markham and A.L. Shroyer, Detection of human papillomavirus in anorectal squamous cell carcinoma. Correlation with basaloid pattern of differentiation, Am J Clin Pathol 104 (1995), 299-305.